Blood soluble OX40 (CD134) levels in advanced colorectal cancer

Last updated: 02nd February, 2022

Products are for professional/laboratory use only.

A recent publication in the oncology field revealed that high blood levels of soluble OX40 indicate reduced survival in patients with advanced colorectal cancer (CRC).

The study published in Oncology Reports utilised the IBL Human CD134/OX40 ELISA Assay in the investigation of 22 patients with advanced CRC.

Learn more about the article

Click Here >

Ordering information:

Product Code: IB30168993

Description: CD135/OX40 ELISA

Find out more about the ELISA assay

View assay details >

Contact us for a quote

Contact Us Now >

Request a Quote

Request Quote

Go BackGo Back